Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	42	non-cytoplasmic
43	65	transmembrane
66	93	cytoplasmic
94	119	transmembrane
120	149	non-cytoplasmic
150	168	transmembrane
169	179	cytoplasmic
180	202	transmembrane
203	221	non-cytoplasmic
222	246	transmembrane
247	257	cytoplasmic
258	280	transmembrane
281	305	non-cytoplasmic
306	333	transmembrane
334	348	cytoplasmic
349	371	transmembrane
372	390	non-cytoplasmic
391	408	transmembrane
409	425	cytoplasmic
426	452	transmembrane
453	457	non-cytoplasmic
458	476	transmembrane
477	486	cytoplasmic

Input:
>GFF3445 FitnessBrowser__psRCH2:GFF3445
MTREKPKNLWLSRWGFILAATGSAVGLGNIWKFPYITGEFGGGAFVLMYLLCILAIGVPV
MMCEIAIGRRGRGSPIDAIGRVVRENNGNPLWKAVGGMAMTAGFLILCFYVVVAGWAFAY
TVKMLDGSLAATSVEALGGVFEAHNSNPWQLGGWSLLVALLTLWIVAKGVQKGIENAVRW
MMPGLAVLLLILVGYAVTSGGFDQGFAFLFSFDTSKITGEALLAALGHAFFTLSLASGAI
LTYGSYIPDDQSIARTTFMVAIADTCVALLAGLAIFPIIFANGMDPTAGPGLIFMSLPLA
FQQMPFGTAFGVLFFAMVSIAALTSAISMIEATVAYLNEKHGISRLKAAMGSGAVLLVIS
MLAMLSFNLMSGWTPMGKNFFDWLDYLTSRWMMPLGGIFTVLLAGYALRSEIMRDELNLP
PLGYALWLFMVRYVCPVLILMVFLHALGWLGFDPLQRWYWIAGAIGALTLVGELLRPRVM
PALAGR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server